drugset
drugset / Trial / NCT03739788

An Investigational Study to Evaluate Experimental Medication BMS-986165 Given as a Tablet and Solution in Healthy Male Participants

NCT03739788 ↗

Phase 1 Completed 8 enrolled Bristol-Myers Squibb
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to investigate BMS-986165 given as a tablet in healthy male participants.

Timeline

Start
2018-12-05
Primary completion
2019-02-11
Completion
2019-02-11

Drugs

EvaluationDrugModalityDoseRoute
Subject CRAVACITINIB Small molecule — Oral

Indications

No indication recorded.